<DOC>
	<DOC>NCT00367835</DOC>
	<brief_summary>To assess efficacy and safety of SPD503(guanfacine hydrochloride) in subjects with ADHD and oppositional symptoms.</brief_summary>
	<brief_title>SPD503 (Guanfacine Hydrochloride) in ADHD Plus Oppositional Symptoms</brief_title>
	<detailed_description />
	<mesh_term>Attention Deficit Disorder with Hyperactivity</mesh_term>
	<mesh_term>Guanfacine</mesh_term>
	<criteria>Healthy subjects with ADHD and oppositional symptoms ADHDRS&gt;=24 CGI &gt;=4 Tscore of Opp subscale CPRSR:L &gt;=65 Normal ECG and BP &gt;= 55 lbs</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>October 2010</verification_date>
</DOC>